KPV
Research peptideCalms gut and skin inflammation
Overview
What has it been researched for?
- Protects and repairs the gut lining Main focusEarly evidence
- Calms gut inflammationEarly evidence
- Closes wounds and ulcersEarly evidence
- Lowers inflammationEarly evidence
- Calms reactive, irritated skinEarly evidence
- Antimicrobial action on skin and mucosaEarly evidence
Research protocols
The SBL research protocol and what the literature reports. Not medical advice.
SBL research protocol · no established clinical regimen in people
- Dose
- 500 mcg
- Frequency
- 5-on / 2-off
- Duration
- 6 weeks
- Route
- Subcutaneous (oral para el intestino)
- Evidence level
- Preclinical
Tools
Evidence and studies
See studies →Protocols
Research protocols
SBL research protocol · no established clinical regimen in people
Research use, with no established clinical regimen in people.
- Dose
- 500 mcg
- Frequency
- 5-on / 2-off
- Timing
- cualquier hora
- Duration
- 6 weeks
- Break
- 2 weeks
- Route
- Subcutaneous (oral para el intestino)
- Evidence level
- Preclinical
Example dose
30-unit U-100 insulin syringe · Starting dose of its protocol, with 1 ml of water in the 5 mg vial.
30-unit U-100 insulin syringe · Starting dose of its protocol, with 2 ml of water in the 10 mg vial.
What it pairs with
- BPC-157 For the gut they go together: KPV calms inflammation and BPC-157 repairs the lining; the barrier comes first (ISSCA course, class 2.1).
Preparation and dosing
Quick reference
Preparation
- Diluent
- Bacteriostatic water
Evidence
Each effect with its evidence level and, where available, its source.
- Protects and repairs the gut liningPreclinicalSee study · 2017
- Calms gut inflammationPreclinicalSee study · 2008
- Closes wounds and ulcersPreclinicalSee study · 2006
- Lowers inflammationPreclinicalSee study · 2007
- Calms reactive, irritated skinPreclinicalSee study · 2004
- Antimicrobial action on skin and mucosaPreclinicalSee study · 2000
The science
Mechanisms, studies and references
α-MSH tripeptide
Safety
It makes sense if you want
- Gut health & digestion
- Skin healing & regeneration
- Boost my immunity
It does not make sense if
- Active cancer or oncology treatment in the last 5 years
- Pregnancy or breastfeeding
Talk to your doctor first if this applies (3)
- Autoimmune disease
- Immunosuppressants
- Organ or bone-marrow transplant
The certificate of analysis (CoA) certifies the identity and purity of the batch. It does not certify safety of use.
Verify your batch →For research use only (RUO). This consult is educational and does not replace your doctor.
Questions
Frequently asked questions
What is it reconstituted with, and how much?
With bacteriostatic water: 1 ml into the 5 mg vial, giving 5 mg/ml.
What is the starting dose of the research protocol?
500 mcg, 5-on / 2-off. This is the SBL research protocol, with no established clinical regimen in people.
How long is the cycle, and how long does a vial last?
6 weeks ON / 2 weeks OFF. At the starting dose, the 5 mg vial lasts ~2 sem.
Which route is used in research?
Subcutaneous (oral para el intestino).
When does it make no sense?
It makes no sense with: Active cancer or oncology treatment in the last 5 years, Pregnancy or breastfeeding. Details in the Safety tab.
What is it combined with?
It goes well with BPC-157. The reasons are in the Protocols tab.
How do I check my batch?
With the code on the vial, in the verifier. The CoA certifies the identity and purity of the batch, not safety of use.
For research use only (RUO). This consult is educational and does not replace your doctor.